Inhaled Corticosteroids Continuation in the First Trimester and Pregnancy Outcomes in Women With Asthma

This nationwide cohort study found that continued ICS use during early pregnancy was not associated with increased risks of maternal or neonatal outcomes, despite frequent discontinuation. These findings provide reassuring evidence supporting current guideline recommendations to continue ICS therapy during pregnancy and highlight the importance of individualized risk assessment while maintaining asthma control.

Corresponding Authors: Ju-Young Shin, PhD, School of Pharmacy, Sungkyunkwan University, 2066, Seobu-ro, Jangan-gu, Suwon, Gyeonggi-do 16419, South Korea (shin.jy@skku.edu); Yunha Noh, PharmD, PhD, Department of Pharmacy, College of Pharmacy, Chonnam National University, 77, Yongbong-ro, Buk-gu, Gwangju, South Korea (noh.yh@jnu.ac.kr).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.